Document is current
Any future updates will be listed below
-
Authors
Okada, Atsushi https://orcid.org/0000-0002-0087-4168
Kakuta, Takashi
Tadokoro, Naoki
Tateishi, Emi
Morita, Yoshiaki
Kitai, Takeshi
Amaki, Makoto
Kanzaki, Hideaki
Ohta-Ogo, Keiko
Ikeda, Yoshihiko
Fukushima, Satsuki
Fujita, Tomoyuki
Kusano, Kengo
Noguchi, Teruo
Izumi, Chisato
- License Information
-
More Information
Article History
Received: 15 September 2022
Accepted: 24 May 2023
First Online: 1 June 2023
Declarations
:
: The study was approved by the institutional review board of National Cerebral and Cardiovascular Center (R20090). The authors confirm that written informed consent for submission and publication of this case report has been obtained from the patients.
: Written informed consent was obtained from all patients for publication of this case report. Copies of the consent forms are available for review by the Editor of this journal.
: AO reports grant and personal fees from Pfizer Inc. and personal fees from Alnylam Pharmaceuticals, outside the submitted work. Other authors have nothing to disclose.
